Cite Filings / ABOS / 0001628280-26-001774

Feed Companies Filings Check

Sign in

8-K

Current Report

Acumen Pharmaceuticals, Inc. Filed 2026-01-12 Acc 0001628280-26-001774

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , abos-20260112.htm

Around this filing

2026-03-16 8-K Material agreement · Unregistered share sale · Regulation FD disclosure
2026-01-12 4 CFO & Chief Business Officer sold 6,888 shares at $1.82 ($12,513)
2026-01-12 4 Chief Operating Officer sold 3,530 shares at $1.86 ($6,562)
2026-01-12 4 Chief Legal Officer & Corp Sec sold 50,659 shares at an average $1.80 ($91,073)
2026-01-12 4 Chief Executive Officer sold 26,472 shares at an average $1.77 ($46,954)
2026-01-12 8-K Regulation FD disclosure
2025-11-12 8-K Results of operations · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading abos-20260112.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…